GGrantIndex
Sort

141,003 grants matching cytokine

Elucidating Genetic Determinants of Resistance to Lassa Hemorrhagic Fever

$756,479
Pardis Christine Sabeti · Broad Institute, Inc. · R01 · FY2017 · AI

Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses

$756,432
Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2016 · AI

Role of Follicular T Helper Cells In Enhancing Humoral Immunity and Protection

$756,405
Rafi Ahmed · Emory University · U19 · FY2014 · AI

Specific T and B cell responses to candidate Treponema pallidum outer membrane protein vaccine antigens

$756,388
David M Koelle · University Of Washington · U19 · FY2021 · AI

Multiscale Analysis of Trauma

$756,341
Scott L Diamond · University Of Pennsylvania · U01 · FY2016 · HL

Immunosenescence, socioeconomic disadvantage and dementia in the US aging population

$756,321
Grace A Noppert · University Of Michigan At Ann Arbor · R01 · FY2022 · AG

Environmental ethoxylated surfactants and metabolic health dysregulation in zebrafish

$756,318
Christopher Dennis Kassotis · Wayne State University · R01 · FY2025 · ES

The IL-18-IFNγ axis predicts response to immunotherapy

$756,160
Heather Leigh Herd Gustafson · Seattle Children'S Hospital · R37 · FY2024 · CA

Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation

$756,133
Edmund K. Waller · Emory University · R01 · FY2020 · AI

Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation

$756,133
Edmund K. Waller · Emory University · R01 · FY2021 · AI

The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD

$756,000
Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2020 · AG

The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD

$756,000
Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2023 · AG

The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD

$756,000
Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2022 · AG

The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD

$756,000
Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2021 · AG

mTOR as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target

$755,984
David C Fajgenbaum · University Of Pennsylvania · R01 · FY2018 · HL

Targeting the Active Resolution of Inflammation for Cardiovascular Disease Prevention

$755,921
Samia Mora · Brigham And Women'S Hospital · R01 · FY2025 · HL

Genetic Contribution to Graft and Patient Outcomes

$755,858
Adriana V Zeevi · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · HL

Imaging Brain Signal Transduction In Vivo With Radiolabeled Arachidonic Acid

$755,856
Stanley I Rapoport · Aging · Z01 · FY2007 · AG

Developing Evidence To Inform Regulatory Policy On Nicotine Content In E-Liquids

$755,827
Risa Jean Robinson · Rochester Institute Of Technology · R01 · FY2024 · DA

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome

$755,824
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Development of the neonatal mucosal immune system in nonhuman primates

$755,770
Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2015 · AI

Resolution of inflammation after cardiac arrest

$755,763
Edy Yong Kim · Brigham And Women'S Hospital · R01 · FY2024 · HL

Project Heart: Biobehavioral effects on Cardiovascular Risk for Bereaved Spouses

$755,731
Christopher Paul Fagundes · Rice University · R01 · FY2015 · HL

Tissue Immunity and Repair Program

$755,703
Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Analysis of Host-Pathogen Interactions

$755,694
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI